
|Articles|November 1, 2006
Breast cancer risk in subset of OC users
Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI
2
Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds
3
Individualized TRT demonstrates broad symptom improvements beyond sexual function
4
SMFM in midst of first annual High-Risk Pregnancy Awareness Week
5






